SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-002649
Filing Date
2020-08-12
Accepted
2020-08-12 17:00:51
Documents
47
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q phio_10q-063020.htm 10-Q 418616
2 CERTIFICATION phio_ex3101.htm EX-31.1 7046
3 CERTIFICATION phio_ex3201.htm EX-32.1 3770
  Complete submission text file 0001683168-20-002649.txt   2554388

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE phio-20200630.xml EX-101.INS 451019
5 XBRL SCHEMA FILE phio-20200630.xsd EX-101.SCH 28317
6 XBRL CALCULATION FILE phio-20200630_cal.xml EX-101.CAL 37153
7 XBRL DEFINITION FILE phio-20200630_def.xml EX-101.DEF 109126
8 XBRL LABEL FILE phio-20200630_lab.xml EX-101.LAB 226500
9 XBRL PRESENTATION FILE phio-20200630_pre.xml EX-101.PRE 178231
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 201096078
SIC: 2834 Pharmaceutical Preparations